Since the BRCA1 gene product is known to play a role in DNA double strand break repair [8,9], it has been suggested that decreased repair capacity is the basis of the breast cancer predisposition observed in mutation carriers [32-35]. This evidence concerns the gene BRCA1 and breast carcinoma.